Cryoport (CYRX) Stock Analysis & AI Equity Report

Integrated Freight & Logistics USD Explore free reports

Cryoport (CYRX) overview

Cryoport (CYRX) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 176m and operating profit of USD -36.8m; the year-end share price was 9.60 USD and market capitalisation was USD 479m. Cryoport is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Cryoport's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 503mFY 2025
Share price9.60 USDFY 2025 year end
RevenueUSD 176mFY 2025
Operating profitUSD -36.8mFY 2025
Net earningsUSD 70.3mFY 2025
Market capitalisationUSD 479mFY 2025 year end

About Cryoport

Cryoport provides temperature-controlled supply chain services and products for life sciences customers, including biopharmaceutical and pharmaceutical companies, animal health markets, reproductive medicine, academic institutions, research organizations, and government agencies. Its offerings include specialized transport, biostorage, kitting and labeling, clinical sample management, cell therapy collection and cryopreservation, and cryogenic systems such as freezers, dewars, and transport equipment.

Generate the Cryoport report

Cryoport is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Cryoport and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Cryoport

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.